购物车
- 全部删除
- 您的购物车当前为空
GK563是一种针对Ca2+-independent phospholipase A2(GVIA iPLA2)的选择性抑制剂,具有1 nM的IC50值。相比于GIVA cPLA2,GK563对GVIA iPLA2的抑制活性高出22000倍。它能减少促炎细胞因子诱导的β-cell凋亡,从而增加了其在对抗自身免疫性疾病(例如1型糖尿病)中的潜在应用价值。
GK563是一种针对Ca2+-independent phospholipase A2(GVIA iPLA2)的选择性抑制剂,具有1 nM的IC50值。相比于GIVA cPLA2,GK563对GVIA iPLA2的抑制活性高出22000倍。它能减少促炎细胞因子诱导的β-cell凋亡,从而增加了其在对抗自身免疫性疾病(例如1型糖尿病)中的潜在应用价值。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,620 | 35日内发货 | |
5 mg | ¥ 7,170 | 35日内发货 | |
10 mg | ¥ 12,600 | 35日内发货 |
产品描述 | GK563, a selective Ca 2+-independent phospholipase A2 (GVIA iPLA2) inhibitor, exhibits a potent IC50 value of 1 nM and demonstrates 22,000-fold greater activity against GVIA iPLA2 compared to GIVA cPLA2. Its efficacy in reducing β-cell apoptosis triggered by proinflammatory cytokines suggests potential therapeutic benefits in combating autoimmune disorders, including type 1 diabetes. |
分子量 | 246.34 |
分子式 | C16H22O2 |
CAS No. | 2351820-19-2 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容